Levin Capital Strategies, L.P.

Levin Capital Strategies, L.P. appears in our data through filings on Standard Biotools Inc. shares, published by SEC (Form 4). Over a trading history stretching from 1 November 2016 to 31 March 2019, the count stands at 183 filings.

On the market, this insider has only ever bought: 162 purchases, €28.4M in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

A typical purchase (the median) is worth €26k. On 9 out of 159 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. After 159 purchases with a full 90-day history, the hit rate stands at 70% and the median 90-day move at +17.3%. They describe history only and say nothing certain about the share price ahead.

On 2 April 2019 came the latest disclosure, a transaction in Standard Biotools Inc. The last purchase on record was published on 26 December 2018, which is 2,874 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.